- Vouliez-vous dire
- delay,e.
Résultats de la recherche - 25 results
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021
(2023) Keywords: Alpha COVID-19 Delta Vaccine effectiveness Health Topics: Acute respiratory tract infection Acute luchtweginfectie Infection respiratoire aiguë Service: Maladies virales Virale ziekten ...
Association between SARS-CoV-2 variants and post COVID-19 condition: findings from a longitudinal cohort study in the Belgian adult population
main exposure variable was the type of SARS-CoV-2 variants (i.e. Alpha, Delta, and Omicron), extracted from national surveillance data. The association between the different SARS-CoV-2 variants and PCC ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
SARS-CoV-2 in hospitalised severe acute respiratory illness (SARI) patients ≥ 20 years, combining data from these networks during Alpha (March-June)- and Delta (June-December)-dominant periods, ...
Genomic monitoring of SARS-CoV-2 variants using sentinel SARI hospital surveillance.
and BA.5) and Delta (B.1.617.2) VOC s, with no to 2 weeks delay according to the start of their epidemic growth in the Belgian population. First detection of VOC s B.1.351 and P.1 took longer, but these ...
Time series modelling for wastewater-based epidemiology of COVID-19: A nationwide study in 40 wastewater treatment plants of Belgium, February 2021 to June 2022
of daily flow rate, pepper mild mottle virus (PMM oV) concentration, a measure of human faeces in wastewater, and variants (alpha, delta, and omicron strains) on SARS-CoV-2 RNA levels in wastewater. ...
COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022.
sampling.ResultsWe included 1,932,546 symptomatic individuals, of whom 734,115 tested positive. VE i against Delta waned from an initial estimate of 80% (95% confidence interval (CI): 80-81) to 55% (95% CI: 54-55) ...
Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients.
in 54 patients. Symptomatic COVID-19 was diagnosed in 32% of kidney transplant recipients during a period of 6 months after booster vaccination. During this period, SARS-CoV-2 delta and omicron were ...
Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021–2022
Publication Type: Peer reviewed scientific article Authors: Toon Braeye; Lucy Catteau; Ruben Brondeel; Joris Van Loenhout; Kristiaan Proesmans; Laura Cornelissen; Herman Van Oyen; Veerle Stouten; Pierre Hubin; Matthieu Billuart; Achille Djiena; Romain Mah ...
Response to letter to the editor: “Comments on ‘discrepancies between validated GC‐FID and UHPLC‐DAD methods for the analysis of Δ‐9‐THC and CBD in dried hemp flowers’”
Keywords: CBD delta-9-THC dried hemp flowers Health Topics: Effectiveness and safety of vaccines, medicines and health products- Quality of medical laboratories Efficacité et sécurité des vaccins, ...
Association between COVID-19 Primary Vaccination and Severe Disease Caused by SARS-CoV-2 Delta Variant among Hospitalized Patients: A Belgian Retrospective Cohort Study
Publication Type: Peer reviewed scientific article Authors: Queeny Robalo; Laurane De Mot; Mathil Vandromme; Nina Van Goethem; Andrea Gabrio; Pui Yan Jenny Chung; Marjan Meurisse; Belgian Collaborative Group on COVID-19 Hospital Surveillance; Lucy Catteau ...